Stay updated on Xospata Safety in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.

Latest updates to the Xospata Safety in Relapsed AML Clinical Trial page
- Check5 days agoChange DetectedRevision v3.5.0 was added to the Record History. Revision v3.4.3 was removed from the Record History.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded revision entry v3.4.3 and removed v3.4.2 from the record history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new site revision note, Revision: v3.4.2, was added, and the government-funding notice along with the previous Revision: v3.4.1 entry were removed.SummaryDifference0.5%

- Check48 days agoChange DetectedA site-wide notice about potential delays due to a lapse in government funding was added, and the release version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check55 days agoChange DetectedUI/visual updates to the history view add a glossary toggle, green/red highlights for additions and deletions, and minor wording tweaks including revision info (v3.4.0).SummaryDifference0.6%

- Check69 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4 in the footer, indicating a system update rather than new or altered study data, and there are no changes to study details or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Xospata Safety in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.